These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
    Author: Dionisio P, Bergia R, Caramello E, Graziola M, Valenti M, Bajardi P, Barbera L, Voglino F.
    Journal: Minerva Med; 1985 Feb 18; 76(6):229-34. PubMed ID: 3974937.
    Abstract:
    The effect of long-term intravenous administration of L-carnitine on the lipid pattern of 18 patients on intermittent haemodialysis has been evaluated. Serum levels of carnitine were assayed at the beginning and after 4 months of treatment: no significant change was observed. At the end of our investigation, we found a significant reduction of HDL-cholesterol and a significant increase of triglyceride levels, compared with basal values. On the contrary cholesterol levels did not change. Five of the patients though behaved as responders to the treatment: their triglyceride levels decrease while their carnitine values rose significantly. The Authors discuss the therapeutic importance of L-carnitine and its possible influence on dyslipaemia of uremic haemodialysed patients.
    [Abstract] [Full Text] [Related] [New Search]